NEUROCRINE BIOSCIENCES INC (NBIX) Capital expenditures 2016–2025
NEUROCRINE BIOSCIENCES INC (NBIX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$34.0MFY2025 · since FY2016: $4.1M → $34.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $34.0M | -11.0% |
| FY2024 | $38.2M | +35.0% |
| FY2023 | $28.3M | +71.5% |
| FY2022 | $16.5M | -29.5% |
| FY2021 | $23.4M | +114.7% |
| FY2020 | $10.9M | -25.9% |
| FY2019 | $14.7M | -40.7% |
| FY2018 | $24.8M | +257.3% |
| FY2017 | $6.9M | +68.9% |
| FY2016 | $4.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice